Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Scheffler

Showing results (141-150 of 207) with videos related to

Pageof 21
Sort By:
International Journal of Cancer|November 15, 2018
A plasma metabolite panel as biomarkers for early primary breast cancer detectionBaowen Yuan, Simon Schafferer, Qiuqiong Tang, et al.
Future Oncology (London, England)|July 21, 2021
Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinomaMartin Metzenmacher, Filippo Rizzo, Kato Kambartel, et al.
Journal of the American Chemical Society|February 6, 2023
Data-Centric Heterogeneous Catalysis: Identifying Rules and Materials Genes of Alkane Selective OxidationLucas Foppa, Frederik Rüther, Michael Geske, et al.
Nature|April 28, 2022
FAIR data enabling new horizons for materials researchMatthias Scheffler, Martin Aeschlimann, Martin Albrecht, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 27, 2010
Osteoblastic response in patients with non-small cell lung cancer with activating EGFR Mutations and bone metastases during treatment with EGFR kinase inhibitorsSascha Ansén, Christopher Bangard, Silvia Querings, et al.
NPJ Precision Oncology|November 11, 2024
Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-scoreChristoph Arolt, Andreas H Scheel, Margaret Dugan, et al.
Annals of Clinical and Translational Neurology|February 3, 2015
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20bJens Ingwersen, Til Menge, Britta Wingerath, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 20, 2023
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLCChristoph Arolt, Margaret Dugan, Robert Wild, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2025
Evaluating docetaxel effectiveness in KRAS G12C-mutated NSCLC: insights from a Real-World cohortMatthias Scheffler, Lia Tzala, Karly Louie, et al.
Plos One|January 12, 2013
Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinibMatthias Scheffler, Thomas Zander, Lucia Nogova, et al.
Pageof 21

Showing results (141-150 of 207) with videos related to

Sort By:
Pageof 21
International Journal of Cancer|November 15, 2018
A plasma metabolite panel as biomarkers for early primary breast cancer detectionBaowen Yuan, Simon Schafferer, Qiuqiong Tang, et al.
Future Oncology (London, England)|July 21, 2021
Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinomaMartin Metzenmacher, Filippo Rizzo, Kato Kambartel, et al.
Journal of the American Chemical Society|February 6, 2023
Data-Centric Heterogeneous Catalysis: Identifying Rules and Materials Genes of Alkane Selective OxidationLucas Foppa, Frederik Rüther, Michael Geske, et al.
Nature|April 28, 2022
FAIR data enabling new horizons for materials researchMatthias Scheffler, Martin Aeschlimann, Martin Albrecht, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 27, 2010
Osteoblastic response in patients with non-small cell lung cancer with activating EGFR Mutations and bone metastases during treatment with EGFR kinase inhibitorsSascha Ansén, Christopher Bangard, Silvia Querings, et al.
NPJ Precision Oncology|November 11, 2024
Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-scoreChristoph Arolt, Andreas H Scheel, Margaret Dugan, et al.
Annals of Clinical and Translational Neurology|February 3, 2015
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20bJens Ingwersen, Til Menge, Britta Wingerath, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 20, 2023
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLCChristoph Arolt, Margaret Dugan, Robert Wild, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2025
Evaluating docetaxel effectiveness in KRAS G12C-mutated NSCLC: insights from a Real-World cohortMatthias Scheffler, Lia Tzala, Karly Louie, et al.
Plos One|January 12, 2013
Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinibMatthias Scheffler, Thomas Zander, Lucia Nogova, et al.
Pageof 21